ArticleRheumatology and therapy2026

Evaluation of Injection Site Pain and Adherence in Patients Transitioning from a High to Low Volume Adalimumab Formulation (AVT02, Simlandi®) Across Multiple Indications (EASE PAIN).

Dara K Shahrokh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.